The late-stage CRC cells involve two core pathways: (1) ligand CBLN1 (protein secretion) binds with receptor GRID2; and (2) ligand VWF (extracellular matrix organization) binds with receptor GP5. This evidence concerns the gene GP5 and colorectal carcinoma.